United States

Profile: AtriCure Inc (ATRC.O)

ATRC.O on Consolidated Issue listed on NASDAQ Global Market

4 May 2016
Change (% chg)

$-0.13 (-0.90%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

AtriCure, Inc., incorporated on October 31, 2000, is a medical device company providing atrial fibrillation (Afib) solutions. The Company has three primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The Company offers Isolator Synergy Ablation System. The Company's cryoICE cryosurgery product line offers a range of both single use and reusable cryoablation devices. The Company's AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).

The Company's products are utilized by cardiothoracic surgeons during both open-heart and minimally invasive procedures, either on a concomitant or sole-therapy basis. The Company's Isolator Synergy System, which includes its Isolator Synergy clamps, generator and switchbox, is used for the treatment of persistent and long-standing persistent Afib in patients who are undergoing open concomitant coronary artery bypass grafting, and valve replacement or repair. The Company's radiofrequency (RF) ablation products are indicated for the ablation of cardiac tissue. In the United States, the Company primarily sells its products to medical centers through its direct sales force. AtriCure Europe B.V., the Company's wholly owned subsidiary based in the Netherlands, markets and sells its products across Europe and the Middle East primarily through distributors, while in certain markets, such as Germany, France and the Benelux region, sales are made directly to medical centers. The Company also sells its products to other international distributors, primarily in Asia, South America and Canada. The Company sells enabling technologies, including its Lumitip dissectors and Endoscopic Technologies, Inc.'s (Estech) line of reusable cardiac surgery instruments. The Lumitip dissector is used by surgeons to separate tissues to provide access to anatomical structures that are targeted for ablation. The Estech cardiac surgery instruments are used during surgical procedures for repair or replacement of certain heart valves.

Isolator's Synergy Ablation System and Related Radio Frequency Ablation Devices

The Company's Isolator Synergy System and related RF devices, such as its multifunctional pens, represent its primary product line. The Company's Isolator Synergy System and related RF devices consist of various products, such as Isolator Synergy and Isolator Synergy Access Clamps, Isolator Synergy Ablation and Sensing Unit (ASU), AtriCure Switch Box (ASB), Isolator Multifunctional Pens and Coolrail Linear Ablation Device. The Company sells various configurations of its Isolator Synergy clamps. One configuration is optimized for ablation during open-heart procedures and others for minimally invasive procedures. The Company's clamps are single-use disposables and have jaws that close in a parallel fashion. The ASU is a compact generator that delivers bipolar radio frequency energy to its Isolator Synergy clamps, pens and the Coolrail linear ablation device.

The Company's ASB is a switch box which provides the technology needed for the dual pulsing electrodes in its Isolator Synergy clamps, as well as the ability to connect and toggle between its various RF devices. Isolator multifunctional pens are disposable RF devices that come in two configurations: one that makes linear ablations and one that makes spot ablations. The pens enable surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the device. The Company's Coolrail linear ablation device is a disposable linear RF ablation device designed to enable physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures.

Estech Radio Frequency Ablation Devices

The Company's Estech ablation devices are used in both open and minimally invasive procedures. The Estech ablation devices consist of various products, such as Fusion Surgical Ablation System, Estech Electrosurgical Unit (ESU) and AFfirm Bipolar Pacing Probe. The Fusion Surgical Ablation System's Versapolar technology combines bipolar temperature-controlled radio frequency (TCRF) energy control with monopolar energy. The Estech ESU is a power generator for use with Fusion ablation products. The AFfirm Bipolar Pacing Probe is used to test lesions created in surgically treating the patient's arrhythmia.

cryoICE Cryoablation System

The cryoICE cryoablation system consists of the cryoICE BOX generator along with a range of cryoICE single use and reusable cryosurgery probes. The cryoICE cryoablation system is used to ablate cardiac tissue for the treatment of cardiac arrhythmias, and to provide pain relief to thoracic surgery patients via ablation of peripheral nerves.

AtriClip System

The Company's product line for LAA management includes the AtriClip System. The AtriClip system is designed to exclude the left atrial appendage by mechanically clamping the appendage from the outside, eliminating blood flow between the left atrial appendage and the atrium while avoiding contact with circulating blood. The AtriClip portfolio includes a range of devices with different size clips, as well as different applier lengths and deployment options.

The Company competes with Medtronic, Inc.

Company Address

AtriCure Inc

7555 Innovation Way
MASON   OH   45040-9695
P: +1513.7554100
F: +1513.7554567

Company Web Links

Search Stocks